Ro 09-1470 is a new antifungal agent that belongs to a series of compounds characterized by a tetrahydropyran skeleton with glycine and alkenyl side chains and that inhibits P-450 lanosterol C-14 demethylase 45:151-159, 1992). We have studied the compound's mode of interaction with fungal P-45014DM and its selectivity for the fungal versus mammalian P-450 enzymes. Ro 09-1470 bound to the Saccharomyces cerevisiae P'45014DM by coordinating to the heme with one-to-one stoichiometry. Unlike the azole compounds, it interacted with both ferric and ferrous heme. It was active also against the P-45014DM of Candida albicans.
Sterols are essential cell membrane components of all eukaryotic cells; they function mainly to maintain adequate levels of membrane fluidity and to modulate membranebound enzyme activities (13) . Ergosterol is a fungus-specific sterol required for the vegetative growth of yeast under all conditions. The key step in ergosterol biosynthesis, removal of the 14ca-methyl group from lanosterol, is catalyzed by a cytochrome P-450-containing enzyme named P-450 lanosterol C-14 demethylase (P-45014DM) (2) (3) (4) 16) .
A number of azole derivatives which inhibit ergosterol biosynthesis by affecting P-45014DM activity have been developed as potent antifungal agents. Azole-treated fungal cells accumulate C-14 methyl sterols, thereby disrupting membrane structure and function (7, 24, 25) . A multicopy plasmid expressing the gene for P-45014DM has produced resistance to azole antifungal agents in Saccharomyces cerevisiae (19) and Candida albicans (10) and thus proved that P-45014DM is the primary target of azole antifungal agents. Yoshida and Aoyama (27) and Rodrigues et al. (20) investigated in detail the direct interaction of azole antifungal agents with purified P-45014DM and indicated that these compounds formed low-spin stoichiometric complexes with high affinity, indicating that their azole nitrogens interact with the heme iron.
It has been known for some time that azole antifungal agents also potently inhibit many P-450-mediated reactions involved in steroid hormone (5) and cholesterol (23) biosyntheses, as well as in xenobiotic metabolism (8, 12) . Actually, endocrinal side effects and hepatotoxicity are serious problems accompanying clinical treatment with azole antifungal agents.
Ro 09-1470 is one of a new series of compounds having antifungal properties. We investigated the mode of action for Ro 09-1470 and concluded that it inhibits fungal P-45014DM from several lines of evidence: (i) ergosterol biosynthesis * Corresponding author.
was predominantly inhibited by the compound under conditions in which DNA, RNA, protein, and respiration were not inhibited; (ii) C-14 methyl intermediates of ergosterol biosynthesis were accumulated; (iii) P-45014DM enzyme activity was inhibited in vitro; and (iv) the compound bound to heme of P-45014DM (1). The distinguishing feature of Ro 09-1470 is its structure; it does not have an azole moiety as the group coordinating to the heme of P-45014DM* Instead, an amino group of glycine appears to bind to the iron of the heme.
In this paper, we investigated the specificity of Ro 09-1470 for fungal versus mammalian P-450 enzymes. Ro 09-1470 inhibited fungal P-45014DM more strongly than rat hepatic P-45014DM; its effects on other P-450s were also weak. Ro 09-1470 differed from the azole antifungal agents in its interaction with P-450s. Inhibitory activities against P-450s, affinity for rat microsomes, and stoichiometry in heme binding were compared for Ro 09-1470, ketoconazole, and fluconazole; Ro 09-1470 was more similar to fluconazole than to ketoconazole in those comparative studies.
MATERIALS AND METHODS
Reagents. Pure powdered ketoconazole and miconazole were purchased from Sigma, while fluconazole was purified from tablets of Diflucan (Pfizer). The purity specified by high-performance liquid chromatography was 100%. Itraconazole (9.5% pure) and genaconazole (9.8% pure) were gifts from A. W. Polak (Basel, Switzerland).
Cholesterol biosynthesis assay of rat hepatic cell extract (CE). The assay method of Trzaskos et al. (22) (1) . The radioactivity on the thin-layer chromatography plates was determined with a thin-layer chromatography scanner (Aloka; Radiochromanizer JTC-50). The P-45014DM inhibition activity was calculated from the amounts of 4,4-desmethylsterols relative to those in the control.
Assay of other hepatic P-450s. The livers excised from the nontreated rats (male, 10-week-old Sprague-Dawley rats obtained from Charles River Laboratory) were used to prepare the microsome fraction. The CE obtained by the method described above was centrifuged at 105,000 x g for 2 h to precipitate the microsome fraction. The fraction was suspended in 0.1 M potassium phosphate buffer (pH 7.4) containing 1 mM glutathione, 0.1 mM EDTA, and 20% glycerol. The assay methods forp-nitroanisol 0-demethylation and aminopyrine N-demethylation followed those of Kitagawa (11) , whereas that for aniline hydroxylation followed Kato and Jillette (9) . Spectrophotometric analysis was done by the method described in the next paragraph. The P-450 concentration in the microsomes used for kinetic analysis was 2.2 nmol/ml. Ro 09-1470, ketoconazole, and fluconazole were dissolved in dimethyl sulfoxide, and the assay was performed using sample concentrations between 10 and 1,000 p,M and keeping the dimethyl sulfoxide concentration constant at 2%.
Preparation of S. cerevisiae microsomes and spectrophotometric analysis of P-45014DM. The microsome fractions of S. cerevisiae were prepared by the methods described in a previous paper (1) . The P-450 contents of those fractions were determined according to the methods of Omura and Sato (17) by measuring the reduced carbon monoxide (CO) difference spectrum. The extinction coefficient used for estimating P-450 concentrations was 91 cm-1 mM-1. Interaction of the compounds with P-45014DM was analyzed spectrophotometrically as described in a previous paper (1) . The optical peak height obtained by subtracting the minimum A410 value from the maximum A428 value in the difference spectrum was used to measure the affinity for P-45014DM. The peak height values were 2.08 m-' M-1 for ketoconazole, 2.13 m-1 M-1 for miconazole, 1 Preparation of C. albicans microsomes and P-45014DM assay. We prepared microsome fractions of C. albicans 652 (1) and assayed the P-45014DM by the methods reported for S. cerevisiae in a previous paper (1) .
RESULTS
Effects on in vitro cholesterol biosynthesis in rat liver. Effects of Ro 09-1470 and ketoconazole on in vitro cholesterol biosynthesis were analyzed with a CE of rat liver in which P-45014DM was induced by cholestyramine treatment. In the control, only 4,4-desmethylsterols were detected, indicating that three methyl groups at C-4a, C-40, and C-14 were removed. In contrast, 4,4-dimethylsterols were dominant in the samples treated with 600 ,uM Ro 09-1470 or 15 ,uM ketoconazole (Fig. 1) . This profile was basically identical to that of the fungal cells mentioned in the previous paper (1) and indicated that P-45014DM was the enzyme most sensitive to Ro 09-1470 and the azole antifungal agents in the assay of cholesterol biosynthesis in rat liver.
Selective inhibition of fungal P-45014DM versus rat liver P-45014DM. The inhibitory activities of Ro 09-1470 and the reference azole compounds against rat liver P-45014DM were measured by the method described above ( Interaction with S. cerevisiae P-45014DM. Ketoconazole was reported to bind to P-45014DM at a ratio of 1:1 (27) . We investigated the stoichiometry in the Ro 09-1470 binding to P-45014DM. As we have indicated previously (1), Ro 09-1470 induced a marked spectral change in ferric P-45014DM by coordinating to the heme. Figure 3 represents a result of the spectral titration of S. cerevisiae P-45014DM with Ro 09-1470 and ketoconazole. The spectral changes were linearly dependent on the amount of Ro 09-1470 and ketoconazole and were saturated when equimolar Ro 09-1470 (0.355 ,uM) and ketoconazole (0.328 ,uM) were added to P-45014DM (0.310 ,uM). This observation clearly indicated that Ro 09-1470 and P-45014DM formed a one-to-one complex, as did ketoconazole and the enzyme.
Inhibition of CO binding to S. cerevisiae P-450s. Reduced azole antifungal agent complexes with P-45014DM could be formed by reducing the corresponding ferric complexes with sodium dithionite. The interaction between azole antifungal agents and ferrous P-45014DM, however, is very weak when P-450 heme is reduced prior to the addition of the antifungal agents (27) . We compared the ability of Ro 09-1470 and azole antifungal agents to inhibit CO binding to ferric and ferrous P-45014DM (Table 3 ). The CO difference spectrum of the dithionite-reduced P-450 in the microsomal preparation of S. cerevisiae showed maximum absorption at 448 nm, as reported by Vanden Bossche et al. (24) . Ro 09-1470 showed inhibitory activity against both ferric and ferrous P-45014DMS with similar affinities, whereas ketoconazole and fluconazole inhibited ferrous P-45014DM with much lower affinity, as reported by other researchers (27) . The rank order of selectivity for fungal P-45014DM and mammalian P-45014DM was essentially the same as that for anti-rat hepatic P-45014DM activity. Itraconazole, ketoconazole, and miconazole are known to be lipophilic compounds, (p4) that might occur because of high partition coefficients, lot of the difference spectrum of rat because microsomes were used in both fungal and rat liver o 09-1470 (0), ketoconazole (0), and assays and the membrane distribution efficiency of each compound was compensated for by calculating the selectivity ratios. It has been reported that ketoconazole and miconazole have similar inhibitory activities against rat and human CUSSION hepatic P-45014DM, with IC50s ranging from 0.5 to 1 ,uM (18), but fluconazole does not (23) . Furthermore, the kinetic a14DM lnhibitor as an antifungal parameters of rat and human hepatic P-45014DMS were very yamuate the selectivity of such a similar (18 and P-4502B2), which interact with globular molecules, than of the polyaromatic hydrocarbon-inducible cytochromes P-448 (in the rat, P-4501A1 and P-4501A2), which interact essentially with planar molecules but not with bulky members among the two main P-450 groups of gene families (14) . We investigated the effects of Ro 09-1470 and azole antifungal agents on xenobiotic metabolism usingp-nitroan-I1 1 -isol, aniline, and aminopyrine as substrates. Ketoconazole showed more potent inhibition against aminopyrine N-demethylation catalyzed mainly by P-4502B1 than against p-nitroanisol 0-demethylation catalyzed by P-4501A1 (21) , which agreed with the phenomena described above. Under these , ., . , . affinity to P-450s in rat liver microsomes, Ro 09-1470 inter-11 acted with lower affinity than did ketoconazole but with almost the same activity as did fluconazole.
We have demonstrated in this paper that, on the whole, Ro 09-1470 is a potent inhibitor of fungal P-45014DM but interacts with only low affinity against rat hepatic cytochrome P-450s involved in cholesterol biosynthesis and xenobiotic metabolism. This suggests that Ro 09-1470 might have a larger therapeutic window, if pharmacokinetics are not otherwise different.
In this report we have also demonstrated that Ro 09-1470 combined with ferric P-45014DM heme with one-to-one stoichiometry, as did ketoconazole (27) . The difference spectrum of Ro 09-1470 was also superimposable on that of ketoconazole (1), meaning that the spectral change induced by Ro 09-1470 was the same as that induced by ketoconazole. Ketoconazole was reported to induce a marked type II spectral change of ferric P-45014DM, which was characterized by redshifts and hypochromicity of the Soret and a bands and marked enhancement of the 8 band (27) . This type of spectral change is characteristic for the binding of a basic amino nitrogen to the sixth coordination position of the heme iron (26, 28) . It can thus be concluded that the amino nitrogen in the glycine moiety of Ro 09-1470 bound to the sixth coordination position of the heme iron of P-45014DM.
The magnitudes of the difference spectra in the presence of saturated concentrations of compounds were quite different from one another in our experiments (see Materials and Methods). Two imidazoles (ketoconazole and miconazole) induced the largest difference in the heme spectrum, followed by the triazoles (fluconazole and itraconazole) and the glycine-containing compound (Ro 09-1470). It was reported that the triazole compound-induced difference spectrum was smaller than that induced by the imidazole compound (27) . Our experiments further showed that these differences must depend on the physicochemical properties, such as the basicity, of the coordinating groups of the compounds.
A Ro 09-1470 complex of ferrous P-45014DM interfered with CO binding (Table 3 ). The rank order of IC50s of Ro 09-1470, ketoconazole, and fluconazole was essentially the same as that of P-45014DM inhibition (Table 1 ). It was reported that the inhibitory effects on demethylation activity by azole antifungal agents could be presumed by their ability to interfere with the binding of CO to ferrous P-45014DM (24) . This also seems to be the case for other coordinating groups.
Ro 09-1470 could directly interact with both ferrous and ferric forms of P-45014DM with a similar affinity, whereas ketoconazole and fluconazole showed a difference (Table 3) . Yoshida and Aoyama (27) discussed in their report that larger-molecular azole antifungal agents such as ketoconazole and itraconazole could not interact directly with ferrous P-45014DM and suggested that the crevice of the ferrous enzyme is narrower than that of the ferric enzyme. The fact that the small compound fluconazole also show low affinity for ferrous P-45014DM, however, suggested that (i) the low affinity for the ferrous enzyme of larger-molecule azoles cannot be simply ascribed to the bulkiness of such compounds in the crevice or (ii) the Ro 09-1470 molecule is so small or flexible that it can slip into the active site through the narrow crevice, which is too narrow even for fluconazole.
Although the coordination with heme is similar for both Ro 09-1470 and the azole antifungal agents, this fact alone cannot lead to the conclusion that the modes of interaction are also similar. Further investigation is certainly needed to understand the precise binding topography and the action mode.
